(Total Views: 197)
Posted On: 07/18/2018 2:58:58 PM
Post# of 110093
$ AMFE **
Financials over the last 4 years fiscal year ended June 30th.
Revenues:
2015=292,886.00
2016=279,045.00
2017=6,630,973
2018=11,653,872* does not include 4th Q.
Gross Profits
2015=107,060.00
2016=157,650.00
2017=3,678,780
2018=4,010,107 * does not include 4th @
300M shares were taken off the AS in 2018 leaving 600M
Outstanding shares though quarter 3 = 479,253,160
Not only is the company growing and will easily double 2107 revenues in 2018 they took 300M off the table. No toxic debt either.
Growth + no toxic debt+ decrease in AS+ pps of 2-3 times revenue's= Undervalued long term Monster.
Compliments of CT Investor[Egold]
Note:
Now is the time to buy more shares.
You snooze...You lose!!
Financials over the last 4 years fiscal year ended June 30th.
Revenues:
2015=292,886.00
2016=279,045.00
2017=6,630,973
2018=11,653,872* does not include 4th Q.
Gross Profits
2015=107,060.00
2016=157,650.00
2017=3,678,780
2018=4,010,107 * does not include 4th @
300M shares were taken off the AS in 2018 leaving 600M
Outstanding shares though quarter 3 = 479,253,160
Not only is the company growing and will easily double 2107 revenues in 2018 they took 300M off the table. No toxic debt either.
Growth + no toxic debt+ decrease in AS+ pps of 2-3 times revenue's= Undervalued long term Monster.
Compliments of CT Investor[Egold]
Note:
Now is the time to buy more shares.
You snooze...You lose!!
(1)
(0)
